{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:00:29Z","timestamp":1781715629303,"version":"3.54.5"},"reference-count":119,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jcyt.2021.10.003","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:43:34Z","timestamp":1643157814000},"page":"365-375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Rheumatoid arthritis: From synovium biology to cell-based therapy"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9530-6499","authenticated-orcid":false,"given":"Michaela","family":"Debreova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Culenova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Smolinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1989-7423","authenticated-orcid":false,"given":"Andreas","family":"Nicodemou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Csobonyeiova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5074-9621","authenticated-orcid":false,"given":"Lubos","family":"Danisovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2021.10.003_bib0001","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/014107680409700903","article-title":"Diagnosis of Early Rheumatoid Arthritis: What the Non-Specialist Needs to Know","volume":"97","author":"Suresh","year":"2004","journal-title":"JRSM"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0002","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ca.22980","article-title":"Rheumatoid Arthritis in Review: Clinical Anatomical Cellular and Molecular Points of View: RA in Review","volume":"31","author":"Sharif","year":"2018","journal-title":"Clin Anat"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0003","doi-asserted-by":"crossref","DOI":"10.14573\/altex.1910011","article-title":"Rheumatoid Arthritis Research in the 21st Century: Limitations of Traditional Models New Technologies and Opportunities for a Human Biology-Based Approach","author":"Cassotta","year":"2019","journal-title":"ALTEX"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0004","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/BOR.0000000000000370","article-title":"Mesenchymal Stem Cells for the Management of Rheumatoid Arthritis: Immune Modulation Repair or Both?","volume":"29","author":"Ansboro","year":"2017","journal-title":"Current Opinion in Rheumatology"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/imcb.12311","article-title":"Epigenetics in Rheumatoid Arthritis, Fibroblast-like Synoviocytes as an Emerging Paradigm in the Pathogenesis of the Disease","volume":"98","author":"Karami","year":"2020","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0006","first-page":"1453","article-title":"Mesenchymal Stem Cells: Biological Properties and Clinical Applications Expert Opinion on Biological","volume":"10","author":"Garc\u00eda-G\u00f3mez","year":"2010","journal-title":"Therapy"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0007","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/nyas.12815","article-title":"The Immunomodulatory Function of Mesenchymal Stem Cells: Mode of Action and Pathways: Mesenchymal Stem Cells and Immunity: An Update","volume":"1351","author":"Uccelli","year":"2015","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0008","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human Mesenchymal Stem Cells Modulate Allogeneic Immune Cell Responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0009","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.1780301102","article-title":"The Shared Epitope Hypothesis an Approach to Understanding the Molecular Genetics of Susceptibility to Rheumatoid Arthritis","volume":"30","author":"Gregersen","year":"1987","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0010","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ng.2462","article-title":"High-Density Genetic Mapping Identifies New Susceptibility Loci for Rheumatoid Arthritis","volume":"44","author":"Eyre","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0011","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/BOR.0b013e3283457524","article-title":"Genetics of Rheumatoid Arthritis: Time for a Change!","volume":"23","author":"de Vries","year":"2011","journal-title":"Current Opinion in Rheumatology"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0012","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B","article-title":"Characterizing the Quantitative Genetic Contribution to Rheumatoid Arthritis Using Data from Twins","volume":"43","author":"MacGregor","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0013","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1002\/art.38097","article-title":"Familial Risks and Heritability of Rheumatoid Arthritis: Role of Rheumatoid Factor\/Anti-Citrullinated Protein Antibody Status Number and Type of Affected Relatives Sex and Age: Familial Risk of RA","volume":"65","author":"Frisell","year":"2013","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0014","doi-asserted-by":"crossref","first-page":"e57304","DOI":"10.1371\/journal.pone.0057304","article-title":"On the Origin of Rheumatoid Arthritis: The Impact of Environment and Genes\u2014A Population Based Twin Study","volume":"8","author":"Svendsen","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0015","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/acr.22325","article-title":"Smokeless tobacco (moist snuff) use and the risk of developing rheumatoid arthritis: results from a case-control study","volume":"66","author":"Jiang","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0016","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/ard.2008.096487","article-title":"Impact of Smoking as a Risk Factor for Developing Rheumatoid Arthritis: A Meta-Analysis of Observational Studies","volume":"69","author":"Sugiyama","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0017","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1289\/ehp.0800503","article-title":"Exposure to Traffic Pollution and Increased Risk of Rheumatoid Arthritis","volume":"117","author":"Hart","year":"2009","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0018","article-title":"Microbial Infection and Rheumatoid Arthritis","volume":"4","author":"Li","year":"2013","journal-title":"J Clin Cell Immunol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0019","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1128\/IAI.67.7.3248-3256.1999","article-title":"Purification Characterization and Sequence Analysis of a Potential Virulence Factor from Porphyromonas Gingivalis Peptidylarginine Deiminase","volume":"67","author":"McGraw","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0020","first-page":"70","article-title":"Association of Periodontal Disease and Tooth Loss with Rheumatoid Arthritis in the US Population","volume":"35","author":"de Pablo","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0021","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nrrheum.2009.28","article-title":"Periodontitis in Systemic Rheumatic Diseases","volume":"5","author":"de Pablo","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0022","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1002\/art.39783","article-title":"Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine: DYSBIOSIS CONTRIBUTES TO ARTHRITIS DEVELOPMENT","volume":"68","author":"Maeda","year":"2016","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0023","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/art.40003","article-title":"Evidence of the Immune Relevance of Prevotella Copri a Gut Microbe in Patients With Rheumatoid Arthritis","volume":"69","author":"Pianta","year":"2017","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0024","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.immuni.2006.03.007","article-title":"T Helper Cell Differentiation: Regulation by Cis Elements and Epigenetics","volume":"24","author":"Lee","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.smim.2005.01.007","article-title":"Epigenetic Control of B Cell","volume":"17","author":"Su","year":"2005","journal-title":"Differentiation Seminars in Immunology"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0026","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.cell.2007.08.019","article-title":"The Histone H3 Lysine-27 Demethylase Jmjd3 Links Inflammation to Inhibition of Polycomb-Mediated Gene Silencing","volume":"130","author":"De Santa","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0027","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.biopha.2018.02.030","article-title":"MicroRNA Signature of Regulatory T Cells in Health and Autoimmunity","volume":"100","author":"Soltanzadeh-Yamchi","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0028","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/ar113","article-title":"Fibroblast biology: role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis","volume":"2","author":"Pap","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0029","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00281-017-0634-0","article-title":"Cellular and Molecular Pathways of Structural Damage in Rheumatoid","volume":"39","author":"Harre","year":"2017","journal-title":"Arthritis Semin Immunopathol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0030","doi-asserted-by":"crossref","first-page":"390","DOI":"10.5114\/ceji.2017.72807","article-title":"The Role of Anti-Citrullinated Protein Antibodies (ACPA) in the Pathogenesis of Rheumatoid","volume":"42","author":"Kurowska","year":"2017","journal-title":"Arthritis cejoi"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0031","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00281-017-0624-2","article-title":"Environmental Factors and Hormones in the Development of Rheumatoid Arthritis","volume":"39","author":"Alp\u00edzar-Rodr\u00edguez","year":"2017","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0032","doi-asserted-by":"crossref","first-page":"e98794","DOI":"10.1371\/journal.pone.0098794","article-title":"Association of Cross-Reactive Antibodies Targeting Peptidyl-Arginine Deiminase 3 and 4 with Rheumatoid Arthritis-Associated Interstitial Lung Disease","volume":"9","author":"Giles","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0033","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1002\/art.27552","article-title":"Peptidylarginine Deiminase from Porphyromonas Gingivalis Citrullinates Human Fibrinogen and \u03b1-Enolase: Implications for Autoimmunity in Rheumatoid Arthritis","volume":"62","author":"Wegner","year":"2010","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0034","doi-asserted-by":"crossref","first-page":"178ra40","DOI":"10.1126\/scitranslmed.3005580","article-title":"NETs Are a Source of Citrullinated Autoantigens and Stimulate Inflammatory Responses in Rheumatoid Arthritis","volume":"5","author":"Khandpur","year":"2013","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/BOR.0000000000000017","article-title":"When and Where Does Inflammation Begin in Rheumatoid Arthritis?","volume":"26","author":"Demoruelle","year":"2014","journal-title":"Current Opinion in Rheumatology"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0036","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4081\/reumatismo.2016.892","article-title":"The Onset Site of Rheumatoid Arthritis: The Joints or the Lung?","volume":"68","author":"Cafaro","year":"2016","journal-title":"Reumatismo"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0037","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific Autoantibodies Precede the Symptoms of Rheumatoid Arthritis: A Study of Serial Measurements in Blood Donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0038","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3899\/jrheum.080895","article-title":"Comparison of Threshold Cutpoints and Continuous Measures of Anti-Cyclic Citrullinated Peptide Antibodies in Predicting Future Rheumatoid Arthritis","volume":"36","author":"Chibnik","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0039","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/art.33489","article-title":"Avidity Maturation of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis","volume":"64","author":"Suwannalai","year":"2012","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jaut.2016.03.010","article-title":"B Cell Depletion with Rituximab in Patients with Rheumatoid Arthritis: Multiplex Bead Array Reveals the Kinetics of IgG and IgA Antibodies to Citrullinated Antigens","volume":"70","author":"Cambridge","year":"2016","journal-title":"Journal of Autoimmunity"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0041","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1002\/art.22279","article-title":"Isotype Distribution of ANTI\u2013CYCLIC Citrullinated Peptide Antibodies in Undifferentiated Arthritis and Rheumatoid Arthritis Reflects an Ongoing Immune Response","volume":"54","author":"Verpoort","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0042","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/ard.2008.091355","article-title":"Multiple Antibody Reactivities to Citrullinated Antigens in Sera from Patients with Rheumatoid Arthritis: Association with HLA-DRB1 Alleles","volume":"68","author":"Snir","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0043","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1136\/annrheumdis-2015-208495","article-title":"Identification of an Immunodominant Peptide from Citrullinated Tenascin-C as a Major Target for Autoantibodies in Rheumatoid Arthritis","volume":"75","author":"Schwenzer","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0044","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13075-016-1031-0","article-title":"Antibodies Directed against Endogenous and Exogenous Citrullinated Antigens Pre-Date the Onset of Rheumatoid Arthritis","volume":"18","author":"Johansson","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0045","first-page":"R191","article-title":"Detection of Autoantibodies to Citrullinated BiP in Rheumatoid Arthritis Patients and Pro-Inflammatory Role of Citrullinated BiP in Collagen-Induced Arthritis Arthritis","volume":"13","author":"Shoda","year":"2011","journal-title":"Res Ther"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0046","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.chembiol.2018.03.002","article-title":"The Rheumatoid Arthritis-Associated Citrullinome","volume":"25","author":"Tilvawala","year":"2018","journal-title":"Cell Chemical Biology"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0047","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/art.24622","article-title":"Anti-Cyclic Citrullinated Peptide Antibodies from Rheumatoid Arthritis Patients Activate Complement via Both the Classical and Alternative Pathways","volume":"60","author":"Trouw","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0048","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.30081","article-title":"Immune Complexes Containing Citrullinated Fibrinogen Costimulate Macrophages via Toll-like Receptor 4 and Fc\u03b3 Receptor","volume":"63","author":"Sokolove","year":"2011","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0049","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nrrheum.2015.171","article-title":"Cytokines in Rheumatoid Arthritis \u2014 Shaping the Immunological Landscape","volume":"12","author":"McInnes","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0050","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/art.27386","article-title":"Anti-Citrullinated Protein Antibodies Bind Surface-Expressed Citrullinated Grp78 on Monocyte\/Macrophages and Stimulate Tumor Necrosis Factor \u03b1 Production","volume":"62","author":"Lu","year":"2010","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0051","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI60975","article-title":"Induction of Osteoclastogenesis and Bone Loss by Human Autoantibodies against Citrullinated Vimentin","volume":"122","author":"Harre","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0052","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/annrheumdis-2015-208093","article-title":"Identification of a Novel Chemokine-Dependent Molecular Mechanism Underlying Rheumatoid Arthritis-Associated Autoantibody-Mediated Bone Loss","volume":"75","author":"Krishnamurthy","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0053","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/art.38307","article-title":"Rheumatoid Factor as a Potentiator of Anti-Citrullinated Protein Antibody-Mediated Inflammation in Rheumatoid Arthritis: Interaction Between RF and ACPAs in RA","volume":"66","author":"Sokolove","year":"2014","journal-title":"Arthritis & Rheumatology"},{"issue":"Suppl 10","key":"10.1016\/j.jcyt.2021.10.003_bib0054","first-page":"2176","article-title":"Lung changes detected by high resolution tomography are present in ACPAS positive RA patients already at disease onset","volume":"63","author":"Reynisdottir","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0055","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid Arthritis-Related Interstitial Lung Disease: Associations Prognostic Factors and Physiological and Radiological Characteristics\u2013a Large Multicentre UK Study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0056","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.34344","article-title":"Brief Report: Airways Abnormalities and Rheumatoid Arthritis-Related Autoantibodies in Subjects without Arthritis: Early Injury or Initiating Site of Autoimmunity?","volume":"64","author":"Demoruelle","year":"2012","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0057","doi-asserted-by":"crossref","DOI":"10.1002\/art.38066","article-title":"Sputa Autoantibodies in Patients with Established Rheumatoid Arthritis and Subjects At-Risk for Future Clinically Apparent Disease","author":"Willis","year":"2013","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0058","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pathophys.2005.07.005","article-title":"Synovial Biology and T Cells in Rheumatoid Arthritis","volume":"12","author":"Tran","year":"2005","journal-title":"Pathophysiology"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0059","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The Pathogenesis of Rheumatoid Arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0060","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/ard.2004.029751","article-title":"Synovial Tissue Macrophages: A Sensitive Biomarker for Response to Treatment in Patients with Rheumatoid Arthritis","volume":"64","author":"Haringman","year":"2005","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0061","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.autrev.2009.12.013","article-title":"Neutrophils in Rheumatoid Arthritis: More than Simple Final Effectors","volume":"9","author":"Casc\u00e3o","year":"2010","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0062","first-page":"943","article-title":"Identification of Cell Types Responsible for Bone Resorption in Rheumatoid Arthritis and Juvenile Rheumatoid Arthritis","volume":"152","author":"Gravallese","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0063","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1002\/art.11219","article-title":"Rheumatoid Fibroblast-like Synoviocytes Overexpress the Chemokine Stromal Cell-Derived Factor 1 (CXCL12) Which Supports Distinct Patterns and Rates of CD4+ and CD8+ T Cell Migration within Synovial Tissue","volume":"48","author":"Bradfield","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0064","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/art.21930","article-title":"Differential Survival of Leukocyte Subsets Mediated by Synovial Bone Marrow and Skin Fibroblasts: Site-Specific versus Activation-Dependent Survival of T Cells and Neutrophils","volume":"54","author":"Filer","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12891-015-0516-3","article-title":"Differential Expression of Pro-Inflammatory Cytokines IL-15Ralpha IL-15 IL-6 and TNFalpha in Synovial Fluid from Rheumatoid Arthritis Patients BMC","volume":"16","author":"Santos Savio","year":"2015","journal-title":"Musculoskelet Disord"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0066","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jim.2013.08.007","article-title":"Chemokine and Cytokine Levels in Osteoarthritis and Rheumatoid Arthritis Synovial Fluid","volume":"396","author":"Hampel","year":"2013","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0067","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/art.1780140407","article-title":"Lactate Oxygen and Carbon Dioxide Partial Pressure in Various Joint Diseases","volume":"14","author":"Treuhaft","year":"1971","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0068","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/art.1780130606","article-title":"Oxygen Tension in Synovial Fluids","volume":"13","author":"Lund-Olesen","year":"1970","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0069","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/ar1447","article-title":"Oxidation in Rheumatoid Arthritis","volume":"6","author":"Hitchon","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0070","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7","article-title":"Expression of Hypoxia-Inducible Factor 1alpha by Macrophages in the Rheumatoid Synovium: Implications for Targeting of Therapeutic Genes to the Inflamed Joint","volume":"44","author":"Hollander","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0071","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrrheum.2016.69","article-title":"Hypoxia Mitochondrial Dysfunction and Synovial Invasiveness in Rheumatoid","volume":"12","author":"Fearon","year":"2016","journal-title":"Arthritis Nat Rev Rheumatol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0072","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/1529-0131(200109)44:9<2055::AID-ART355>3.0.CO;2-2","article-title":"Raised Serum Vascular Endothelial Growth Factor Levels Are Associated with Destructive Change in Inflammatory Arthritis","volume":"44","author":"Ballara","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0073","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/ard.57.12.703","article-title":"Influence of Hypoxia in Inflammatory Synovitis","volume":"57","author":"Bodamyali","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0074","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/art.27287","article-title":"Angiogenesis and Blood Vessel Stability in Inflammatory Arthritis","volume":"62","author":"Kennedy","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0075","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1136\/ard.2009.119776","article-title":"Synovial Tissue Hypoxia and Inflammation in Vivo","volume":"69","author":"Ng","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"Pt 2","key":"10.1016\/j.jcyt.2021.10.003_bib0076","first-page":"459","article-title":"Oxidative Damage to Hyaluronate and Glucose in Synovial Fluid during Exercise of the Inflamed Rheumatoid Joint Detection of Abnormal Low-Molecular-Mass Metabolites by Proton-nmr","volume":"273","author":"Grootveld","year":"1991","journal-title":"Spectroscopy Biochem J"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0077","first-page":"479","article-title":"Evidence for Oxidised Low Density Lipoprotein in Synovial Fluid from Rheumatoid Arthritis Patients Free","volume":"32","author":"Dai","year":"2000","journal-title":"Radic Res"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0078","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0009-8981(03)00003-2","article-title":"Protein carbonyl groups as biomarkers of oxidative stress","volume":"329","author":"Dalle-Donne","year":"2003","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0079","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0006-2952(99)00290-7","article-title":"Cell Type-Specific Role for Reactive Oxygen Species in Nuclear Factor-KappaB Activation by Interleukin-1","volume":"59","author":"Bonizzi","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0080","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1128\/MCB.19.3.1950","article-title":"Reactive Oxygen Intermediate-Dependent NF-KappaB Activation by Interleukin-1beta Requires 5-Lipoxygenase or NADPH Oxidase Activity","volume":"19","author":"Bonizzi","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0081","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00281-017-0633-1","article-title":"Cellular and Molecular Perspectives in Rheumatoid Arthritis","volume":"39","author":"Veale","year":"2017","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0082","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/ar1478","article-title":"The Role of T-Cell Interleukin-17 in Conducting Destructive Arthritis: Lessons from Animal Models","volume":"7","author":"Lubberts","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0083","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.4049\/jimmunol.173.4.2825","article-title":"Ex Vivo Homeostatic Proliferation of CD4+ T Cells in Rheumatoid Arthritis Is Dysregulated and Driven by Membrane-Anchored TNFalpha","volume":"173","author":"Wagner","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0084","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4049\/jimmunol.173.2.1463","article-title":"IL-15 and the Initiation of Cell Contact-Dependent Synovial Fibroblast-T Lymphocyte Cross-Talk in Rheumatoid Arthritis: Effect of Methotrexate","volume":"173","author":"Miranda-Car\u00fas","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0085","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-Cell-Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0086","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.bmt.1704570","article-title":"A Phase II Study of Rituximab in Rheumatoid Arthritis Patients with Recurrent Disease Following Haematopoietic Stem Cell Transplantation","volume":"34","author":"Moore","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0087","article-title":"Update on the Pathomechanism Diagnosis and Treatment Options for Rheumatoid","volume":"9","author":"Lin","year":"2020","journal-title":"Arthritis Cells"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0088","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00281-017-0627-z","article-title":"The Role of Autoantibodies in the Pathophysiology of Rheumatoid Arthritis","volume":"39","author":"Derksen VF a","year":"2017","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0089","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/art.21405","article-title":"Clinical and Radiographic Outcomes of Four Different Treatment Strategies in Patients with Early Rheumatoid Arthritis (the BeSt Study): A Randomized Controlled Trial","volume":"52","author":"Goekoop-Ruiterman","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0090","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 Inflammasome: Molecular Activation and Regulation to Therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0091","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/cei.13167","article-title":"NLRP3 Inflammasome Activation Contributes to the Pathogenesis of Rheumatoid Arthritis","volume":"194","author":"Guo","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0092","series-title":"Proceedings of the Saturday 16 JUNE 2018, BMJ Publishing Group Ltd and European League Against Rheumatism","first-page":"8942","article-title":"SAT0061 Targeting Activated Synovial Fibroblasts Using Photodynamic Therapy in Rheumatoid Arthritis","author":"Dorst","year":"2018"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0093","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.joms.2007.04.008","article-title":"Adult Mesenchymal Stem Cells: Biological Properties Characteristics and Applications in Maxillofacial Surgery","volume":"65","author":"Shanti","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0094","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal Criteria for Defining Multipotent Mesenchymal Stromal Cells The International Society for Cellular Therapy Position Statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0095","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1517\/14712598.2010.519333","article-title":"Mesenchymal Stem Cells: Biological Properties and Clinical Applications Expert","volume":"10","author":"Garc\u00eda-G\u00f3mez","year":"2010","journal-title":"Opin Biol Ther"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0096","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P","article-title":"Multipotent Mesenchymal Stem Cells from Adult Human Synovial Membrane","volume":"44","author":"De Bari","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0097","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/1529-0131(200101)44:1<85::AID-ANR12>3.0.CO;2-6","article-title":"Human Periosteum-Derived Cells Maintain Phenotypic Stability and Chondrogenic Potential throughout Expansion Regardless of Donor Age","volume":"44","author":"De Bari","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0098","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/art.24405","article-title":"Treatment of Experimental Arthritis by Inducing Immune Tolerance with Human Adipose-Derived Mesenchymal Stem Cells","volume":"60","author":"Gonz\u00e1lez","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0099","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/ard.2008.101881","article-title":"Human Adipose-Derived Mesenchymal Stem Cells Reduce Inflammatory and T Cell Responses and Induce Regulatory T Cells in Vitro in Rheumatoid Arthritis","volume":"69","author":"Gonzalez-Rey","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0100","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4049\/jimmunol.0902007","article-title":"Mesenchymal Stem Cells Inhibit Human Th17 Cell Differentiation and Function and Induce a T Regulatory Cell Phenotype","volume":"185","author":"Ghannam","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0101","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.4049\/jimmunol.1401776","article-title":"Conversion of Th17 into IL-17A(Neg) Regulatory T Cells: A Novel Mechanism in Prolonged Allograft Survival Promoted by Mesenchymal Stem Cell-Supported Minimized Immunosuppressive Therapy","volume":"193","author":"Obermajer","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0102","first-page":"64","article-title":"Human T Follicular Helper (Tfh) Cells and Disease Immunol","volume":"92","author":"Ma","year":"2014","journal-title":"Cell Biol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0103","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00296-019-04296-7","article-title":"Secretory Factors Produced by Adipose Mesenchymal Stem Cells Downregulate Th17 and Increase Treg Cells in Peripheral Blood Mononuclear Cells from Rheumatoid Arthritis Patients","volume":"39","author":"Vasilev","year":"2019","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0104","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s00296-011-1984-x","article-title":"Disturbed Th17\/Treg Balance in Patients with Rheumatoid Arthritis","volume":"32","author":"Niu","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0105","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3562753","article-title":"The Sufficient Immunoregulatory Effect of Autologous Bone Marrow-Derived Mesenchymal Stem Cell Transplantation on Regulatory T Cells in Patients with Refractory Rheumatoid Arthritis","volume":"2020","author":"Ghoryani","year":"2020","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0106","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/annrheumdis-2013-204147","article-title":"Mesenchymal Stem Cell Therapy in Proteoglycan Induced Arthritis","volume":"74","author":"Swart","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0107","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1479-5876-9-181","article-title":"Stem Cell Treatment for Patients with Autoimmune Disease by Systemic Infusion of Culture-Expanded Autologous Adipose Tissue Derived Mesenchymal Stem Cells","volume":"9","author":"Ra","year":"2011","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0108","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10067-011-1816-0","article-title":"Allogeneic Mesenchymal Stem Cells Transplantation in Patients with Refractory RA","volume":"31","author":"Liang","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0109","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/annrheumdis-2015-208918","article-title":"Intravenous Administration of Expanded Allogeneic Adipose-Derived Mesenchymal Stem Cells in Refractory Rheumatoid Arthritis (Cx611): Results of a Multicentre Dose Escalation Randomised Single-Blind Placebo-Controlled Phase Ib\/IIa Clinical Trial","volume":"76","author":"\u00c1lvaro-Gracia","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0110","first-page":"3192","article-title":"Human Umbilical Cord Mesenchymal Stem Cell Therapy for Patients with Active Rheumatoid Arthritis: Safety and Efficacy Stem Cells","volume":"22","author":"Wang","year":"2013","journal-title":"Dev"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0111","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.2147\/DDDT.S225613","article-title":"Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis Patients: A Prospective Phase I\/II Study Drug Des","volume":"13","author":"Wang","year":"2019","journal-title":"Devel Ther"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0112","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12967-018-1541-4","article-title":"Serum IFN-\u03b3 Levels Predict the Therapeutic Effect of Mesenchymal Stem Cell Transplantation in Active Rheumatoid Arthritis","volume":"16","author":"Yang","year":"2018","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0113","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1136\/annrheumdis-2020-217798","article-title":"Combination of Human Umbilical Cord Mesenchymal Stem (Stromal) Cell Transplantation with IFN-\u03b3 Treatment Synergistically Improves the Clinical Outcomes of Patients with Rheumatoid Arthritis","volume":"79","author":"He","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0114","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.biopha.2018.11.056","article-title":"Amelioration of Clinical Symptoms of Patients with Refractory Rheumatoid Arthritis Following Treatment with Autologous Bone Marrow-Derived Mesenchymal Stem Cells: A Successful Clinical Trial in Iran","volume":"109","author":"Ghoryani","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144336","article-title":"A Significant Decrease of BAFF APRIL and BAFF Receptors Following Mesenchymal Stem Cell Transplantation in Patients with Refractory Rheumatoid Arthritis","volume":"732","author":"Gowhari Shabgah","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0116","first-page":"191","article-title":"Possible Anti-Inflammatory Effects of Mesenchymal Stem Cells Transplantation via Changes in CXCL8 Levels in Patients with Refractory Rheumatoid Arthritis","volume":"8","author":"Gowhari Shabgah","year":"2019","journal-title":"Int J Mol Cell Med"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0117","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/sctm.18-0031","article-title":"Intravenous Infusion of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Rheumatoid Arthritis: A Phase Ia Clinical Trial Stem","volume":"7","author":"Park","year":"2018","journal-title":"Cells Transl Med"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0118","article-title":"Mesenchymal Stem\/Stromal Cells for Rheumatoid Arthritis Treatment: An Update on","volume":"9","author":"Lopez-Santalla","year":"2020","journal-title":"Clinical Applications Cells"},{"key":"10.1016\/j.jcyt.2021.10.003_bib0119","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1242\/jcs.00369","article-title":"Molecular and Cellular Characterisation of Highly Purified Stromal Stem Cells Derived from Human Bone Marrow","volume":"116","author":"Gronthos","year":"2003","journal-title":"J Cell Sci"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324921008550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324921008550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:45:23Z","timestamp":1761443123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324921008550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1465324921008550"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2021.10.003","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rheumatoid arthritis: From synovium biology to cell-based therapy","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2021.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society for Cell &#38; Gene Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}